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Background: The present study was aimed to investigate the antinociceptive and anti-inflammatory activity of the
Curcuma zedoaria (family Zingiberaceae) ethanolic rhizome extract in laboratory using both in vitro and in vivo
methods so as to justify its traditional use in the above mentioned pathological conditions.
Methods: Phytochemical screening was done to find the presence of various secondary metabolites of the plant. In
vivo antinociceptive activity was performed employing the hot plate method, acidic acid induced writhing test and
formalin induced writhing test on Swiss albino mice at doses of 250 and 500 mg/kg body weight. Anti-inflammatory
activity test was done on Long Evans rats at two different doses (250 and 500 mg/kg body weight) by using
carrageenan induced paw edema test. Finally in vitro anti-inflammatory test by protein-denaturation method was
followed. Data were analyzed by one-way analysis of variance (ANOVA) and Dunnett’s t-test was used as the test
of significance. P value <0.05 was considered as the minimum level of significance.
Results: Phytochemical screening revealed presence of tannins, saponins, flavonoids, gums & carbohydrates,
steroids, alkaloids, reducing sugars and terpenoids in the extract. In the hot plate method, the extract increased
the reaction time of heat sensation significantly to 61.99% and 78.22% at the doses of 250 and 500 mg/kg BW
respectively. In acetic acid induced writhing test, the percent inhibition of writhing response by the extract was
48.28% and 54.02% at 250 and 500 mg/kg doses respectively (p < 0.001). The extract also significantly inhibited the
licking response in both the early phase (64.49%, p < 0.01) and the late phase (62.37%, p < 0.01) in formalin induced
writhing test. The extract significantly (p < 0.05, p < 0.01 and p < 0.001) inhibited carrageenan induced inflammatory
response in rats in a dose related manner. In in-vitro anti-inflammatory test, the extract significantly inhibited protein
denaturation of 77.15, 64.43, 53.04, 36.78 and 23.70% for doses of 500, 400, 300, 200 and 100 μg/mL respectively.
Conclusions: The results obtained from the tests indicate that the plant might have one or more secondary
metabolite(s) having central and peripheral analgesic and anti-inflammatory activity.
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Table 1 Qualitative analysis of the phytochemicals of Curcuma zedoaria
Plant in extract Tannins Flavonoids Saponins Gums carbohydrate Steroids Alkaloids Reducing sugar Terpenoids
Ethanolic rhizome extract
of Curcuma zedoaria
+++ ++ +++ +++ +++ +++ +++ +++
Symbol (+++) indicates presence in high concentration, Symbol (++) indicates presence in moderate concentration, Symbol (+) indicates presence in
trace concentration.
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The majority population of the developing world relies
on traditional herbal medicine as the primary source of
treatment for illnesses [1]. The issue of compliance with
herbal medicines varies according to local beliefs and
socio-cultural status, and is less reliant on the efficacy of
the traditional medicine.
About 25% of the drugs prescribed worldwide come
from plants, 121 such active compounds being in current
use of the 252 drugs considered as basic and essential by
the World Health Organization (WHO), 11% are exclu-
sively of plant origin and a significant number are syn-
thetic drugs obtained from natural precursors.
Modern social context and economic view of health
services, the needs of the pharmaceutical market and the
recognition that research on medicinal plants used in
folk medicine represents a suitable approach for the de-
velopment of new drugs [2,3] have led to an increase in
the number of publications in this field, and private and
governmental institutions are now financially supporting
research programs worldwide.
It is estimated that, in 1997, the world market for over
the-counter phytomedicinal products was US$ 10 billion,
with an annual growth of 6.5% [4]. In 2003, growth was
well over expectation with sales exceeding USD 65 billion,
with USD 9 billion in Europe alone. The WHO considers
phytotherapy in its health programs and suggests basic
procedures for the validation of drugs from plant origin in
developing countries [5]. China and India have a well-
established herbal medicines industry and Latin American
countries have been investing in research programs in me-
dicinal plants and the standardization and regulation of
phytomedicinal products.
As mentioned earlier, interest in herbal medicine as a
path to drug development increased greatly in the earlyTable 2 Analgesic activity study of the ethanol extract of Cur
Treatment 0 min 30 min 60 min
Control 10.70 ± 0.84676 9.6600 ± 0.93680 8.0000 ± 0.8142
Standard 9.1400 ± 0.52402 11.0200 ± 1.00170* 12.6000 ± 0.9449
Drug250 mg/kg 8.4200 ± 0.34409 9.7400 ± 0.42261 10.9800 ± 0.3733
Drug500 mg/kg 7.4400 ± 0.60795 8.9200 ± 0.48724 10.4000 ± 0.4301
All values are Mean ± SEM, n = 5. One way Analysis of Variance (ANOVA) followed b
of p < 0.05 was considered significant. **p < 0.01, ***p < 0.001 as compared with co1980s [6]. This could be due to the inefficiency of con-
ventional medicine (e.g. cytotoxicity, side effects and in-
effectiveness of synthetic drugs), abusive and incorrect
use of synthetic drugs and most importantly, the high
cost involved in conventional medicine and the fact that
a large percentage of the world’s population does not
have access to conventional pharmacological treatment.
With the limitations of synthetic chemistry, there also
arises the need to find new medicines to combat the
emergence of multi-resistant pathogens [6], as well as to
manage a whole range of chronic and difficult-to-treat
diseases such as cancer, diabetes and AIDS. Natural
products offer unmatched structural variety and their
usefulness can be extended by probing biological path-
ways [7].
Inflammation is a complex biological response of vas-
cular tissues to harmful stimuli. It is also a protective at-
tempt by the organism to remove the injurious stimuli
and initiate the healing process [8]. At the onset of an
inflammation, the cells undergo activation and release
inflammatory mediators. These mediators include hista-
mine, serotonin, slow reacting substances of anaphylaxis
(SRS-A), prostaglandins and some plasma enzyme sys-
tems such as the complement system, the clotting sys-
tem, the fibrinolytic system and the kinin system [9].
These mediator molecules work collectively to cause in-
creased vasodilatation and permeability of blood vessels.
Thus, leading to increased blood flow, exudation of
plasma proteins and fluids, and migration of leukocytes,
mainly neutrophils, outside the blood vessels into the in-
jured tissues. Inflammation can be classified as either
acute or chronic inflammation [8]. Acute inflammation
is the initial response of the body to injurious stimuli
and is achieved by increased movement of plasma and
leukocytes from the blood into the injured tissues. Thecuma zedoaria using the hot plate method
120 min 180 min 240 min
5 6.5800 ± 0.64062 5.5200 ± 0.54900 5.0000 ± 0.44272
9*** 14.1600 ± 1.07638*** 15.9600 ± 0.67646*** 12.4800 ± 0.69814**
6* 12.1800 ± 0.15620*** 13.6400 ± 0.22045*** 11.2100 ± 0.025768**
2* 12.0000 ± 0.20494*** 13.2600 ± 0.14697*** 10.0000 ± 0.24819**
y Dennett’s test was performed as the test of significance. The minimum value
ntrol group.
Table 3 Percentage inhibition of Curcuma zedoaria at
different time intervals
Treatment group % inhibition
½ Hour 1 Hour 2 Hours 3 Hours 4 Hours
Standard 20.56 37.85 54.92 74.61 36.54
250 mg/kg Extract 15.67 30.40 44.65 61.99 33.13
500 mg/kg extract 19.89 39.78 53.20 78.22 34.4
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present in the tissues. This is characterized by marked
vascular changes, including vasodilatation and increased
capillary permeability which are induced by the actions
of the various inflammatory mediators. Chronic inflam-
mation is a prolonged inflammatory response that leads
to a progressive shift in the type of cells present at the
site of inflammation and is characterized by simultan-
eous destruction and healing of the tissues from the in-
flammatory process.
Zedoary (Curcuma zedoaria) is the name for a perennial
herb and member of the genus Curcuma Linn. Family:
Zingiberaceae. It is also known as White Turmeric. The
plant is native to India and Indonesia. It was introduced
to Europe by Arabs around the sixth century, but its use
as a spice in the West today is extremely rare, having
been replaced by ginger.
Zedoary, also known as white turmeric, is a rhizome
with a thin brown skin and a bright orange, hard inter-
ior. Its smell is similar to that of turmeric and mango.
The perennial herb has a warm-spicy, woody and cam-
phoraceous cineolic odor and bears yellow shiny flowers,
with red and green bracts. The ovate leaves possessFigure 1 Comparison graph of Curcuma zedoaria with control and stapurple-colored spots and are 1 to 2 feet long, narrowing
at the base.
Traditionally the plant is used to for a variety of
disease conditions. The paste prepared from the plant
is used to treat inflammation, pain, wounds and skin
ailments. Power prepared from the dried plant is used
to treat menstrual irregularities. The bitter tincture of
zedoary rhizome is used for the treatment of recur-
ring diseases like malaria fever. It is also used to treat
ulcers.
Previous works investigating analgesic property [10]
and anti-inflammatory potential [11] carried out using
extracts from different parts of the plant on laboratory
animals. Therefore the present study was undertaken
employing both in vitro and in vivo methods to explore
possible antinociceptive and anti-inflammatory potential
of the ethanolic rhizome extract of Curcuma zedoaria so
as to establish a plausible mechanism of action of extract
and to justify the traditional uses of this plant.
Methods
Collection and proper identification of the plant sample
The plant was Curcuma zedoaria. It was collected from
Savar, Bangladesh during the month of February. The
whole plant was collected and sun dried. The plant was
identified by the experts of Bangladesh National Herbar-
ium (BNH), Mirpur, Dhaka and was given an accession
number which was 38765. The specimen was preserved
in BNH.
Preparation of powdered plant material
The collected plant was washed with water, separated
from undesirable materials. They were put under sunshadendard.
Figure 2 Graph showing the % of inhibition of the ethanol extract of Curcuma zedoaria using the hot plate method.
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oven to be fully dried at below 40°C for two days. The
fully dried leaves were then grinded to make them pow-
der by the help of a suitable grinder. The powder ob-
tained was extracted via the method of cold extraction
using ethanol and then kept for a period of 5 days ac-
companying occasional shaking and stirring. The whole
mixture then underwent a coarse filtration through a
piece of clean, white cotton material followed by a sec-
ond filtration through Whatman no. 1 filter paper. The
filtrate (ethanol extract) obtained was evaporated by ro-
tary evaporator (Bibby RE-200, Sterilin Ltd., UK) at 5 to
6 rpm and at 68°C temperature. It rendered a gummy
concentrate of dark greenish-black color that was desig-
nated as crude ethanolic extract. The extract was finally
dried by a freeze drier and preserved.
Animals
Young Swiss-Albino mice aged about 4–5 weeks with
average weight of 25–35 gm and adult Long Evans Rats
of either sex having average weight of 100–130 gm were
used for the experiment and maintained in the animal
house of the Department of Pharmacy, North SouthTable 4 Analgesic activity test of Curcuma zedoaria by
Acetic Acid induced
Treatment Total Writhing Counts Mean ± SE % Inhibition
Control 19 11 16 15 26 17.4 ± 2.50 -
Standard 4 6 6 8 7 6.2 ± 0.66*** 64.36
250 mg/kg 7 8 10 9 11 9 ± 0.71** 48.28
500 mg/kg 10 8 9 6 7 8 ± 0.71*** 54.02
All values are Mean ± SEM, n = 5. One way Analysis of Variance (ANOVA)
followed by Dennett’s test was performed as the test of significance. The
minimum value of p < 0.05 was considered significant. *p < 0.05, **p < 0.01,
***p < 0.001 as compared with control group.University for acclimation. The animals were originally
obtained from International Centre for Diarrheal Disease
Research, Bangladesh (ICDDR, B). They were housed in
standard cages under standard environmental conditions
of room temperature at 24 ± 1°C and 55-65% relative hu-
midity with 12 hour dark light cycle and provided with
standard food for rodents and water ad libitum. The ex-
perimental protocol was approved by the Ethics commit-
tee of the North South University and was performed
according to the Guidelines for Animal experimentation
established by the International Centre for Diarrhoeal
Disease Research, Bangladesh (ICDDR, B).
Method for phytochemical analysis
The freshly prepared extract of C. zedoaria was qualita-
tively tested for the presence of chemical constituents.
Qualitative phytochemical tests for the identification of
alkaloids, flavonoids, steroids, gum and carbohydrates,
saponins, reducing sugar, tannins and terpenoids were
carried out for the extract by the method described pre-
viously [12].
Method for the evaluation of analgesic effect
Hot plate test
The hot-plate test (Hot/Cold Plate Model-35100-001,
UGO Basile, Italy) was employed for measurement of
analgesic activity as previously described by Lanhers
et al. and modified by Ojewole [13,14]. The temperature
was regulated at 55° ± 1°C. Mice of either sex were di-
vided into four groups consisting of six animals in each
group. The mice of each group were placed in the bea-
ker (on the hot plate) in order to obtain its response to
electrical heat induced pain stimulus. Licking of the
paws or jumping out of the beaker was taken as an indi-
cator of the animal’s response to heat-induced pain
Figure 3 Comparison curve of analgesic activity of Curcuma zedoaria by acetic acid induced writhing method with control and
standard groups.
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jump out of the beaker was taken as reaction time (in
second). Before treatment, the reaction time was taken
once. The mean of this determination constituted initial
reaction time before treatment of each group of mice.
Each of the test mice was thereafter treated with either
distilled water (DW), Diclofenac sodium (10 mg/kg BW)
or ethanol extract of C. zedoaria at the doses of 250 and
500 mg/kg BW orally. Thirty minutes after treatment,
the reaction times of each group of mice were again
evaluated five times individually on one hour interval.
Percent analgesic score was calculated as,
Percent Analgesic Score ¼ Ta−Tb
Ta
 100
Where, Tb = Reaction time (in second) before drug ad-
ministration; Ta = Reaction time (in second) after drug
administration.
Acetic acid-induced writhing method
The analgesic activity of the sample was evaluated using
acetic acid induced writhing method in mice followingFigure 4 Percentage inhibition of Curcuma zedoaria by acetic acid indthe method of Koster et al. with slight modification
[15-17]. In this method, acetic acid is administered in-
traperitoneally to the experimental animals to create
pain sensation. The animals were divided into four
groups with six mice in each group. Group I animals re-
ceived distilled water, Group II received Diclofenac so-
dium at 10 mg/kg while animals of Group III and
Group IV were treated with 250 and 500 mg/kg of the
ethanol extract of C. zedoaria after an overnight fast.
Test samples and vehicle were administered orally
30 minutes prior to intraperitoneal administration of
0.7% v/v acetic acid solution. Animals were kept indi-
vidually under glass jar for observation. Each mouse of
all groups was observed individually for counting the
number of writhing they made in 10 minutes commen-
cing just 5 minutes after the intraperitoneal administra-
tion of acetic acid solution. Full writhing was not always
accomplished by the animal, because sometimes the an-
imals started to give writhing but they did not complete
it. This incomplete writhing was considered as half-
writhing. Accordingly, two half-writhings were taken as
one full writhing. The number of writhes in each treated
group was compared to that of a control group where
Diclofenac sodium was used as a reference standarduced writhing method with standard.
Table 5 Analgesic activity test of Curcuma zedoaria by
formalin induced writhing method
Early phase (0–5 min) Late phase (20–30 min)
Group Mean ± SE Group Mean ± SE
Control 30.60 ± 5.3 Control 20.20 ± 4.86
Standard 9.8 ± 0.58*** Standard 5.0 ± 0.70***
Drug 250 mg 11.00 ± 0.71*** Drug 250 mg 8.40 ± 0.51**
Drug 500 mg 10.56 ± 0.58*** Drug 500 mg 7.60 ± 0.51***
All values are Mean ± SEM, n = 5. One way Analysis of Variance (ANOVA)
followed by Dennett’s test was performed as the test of significance. The
minimum value of p < 0.05 was considered significant. **p < 0.01, ***p < 0.001 as
compared with control group.
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was calculated as follows:
% Inhibition ¼ 1−VT
VC
 100
VT = number of writhing motions in extract-treated
mice.
VC = number of writhing motions in the control group
of mice.
Formalin induced writhing test
The method used was similar to that described previ-
ously [18,19]. The mice were divided into four groups
each containing 6 mice and were administered with ei-
ther distilled water (1 ml/kg, i.p.), ethanolic extract of C.
zedoaria (250 and 500 mg/kg, i.p) or Diclofenac sodium
(10 mg/kg, s.c). Thirty minutes after this treatment;
50 μL of a freshly prepared 0.6% solution of formalin
was injected subcutaneously under the plantar surface of
the left hind paw of each mice. The mice were placed in-
dividually in an observation chamber and monitored for
one hour. The time (in second) spent in licking and biting
responses of the injected paw was taken as an indicator of
pain response. Anti-nociceptive effect was determined in
two phases. The early phase (phase 1) was recorded dur-
ing the first 5 minutes, while the late phase (phase 2) was
recorded during the last 20–30 minutes after formalin
injection.Table 6 Percentage inhibition of Curcuma zedoaria by
formalin induced writhing method (Early phase and late
phase)
Early phase (0–5 min) Late phase (20–30 min)
Treatment % inhibition Treatment % inhibition
Standard 67.97 Standard 75.25
Drug 250 mg 64.04 Drug 250 mg 58.42
Drug 500 mg 64.49 Drug 500 mg 62.37Method for the evaluation of anti-inflammatory effect
Evaluation of in vivo anti-inflammatory effect
The anti-inflammatory activity of the ethanol extract
was investigated on carrageenan induced inflammation
in rat paw following an established method [20]. Rats
were randomly divided into four groups, each consist-
ing of six animals, of which group I was kept as control
giving only distilled water. Group II was standard which
received Diclofenac sodium (10 mg/kg) as the reference
standard for comparison while Group III and Group IV
were given the test material at a dose of 250 and
500 mg/kg body weight respectively. Half an hour after
the oral administration of the test materials, 1% carra-
geenan was injected to the right hind paw of each ani-
mal. The volume of paw edema was measured at 0, 1, 2,
3, 6 and 9 hours using Plethysmometer (Model 7141,
UGO Basile, Italy) after administration of carrageenan.
The left hind paw served as a reference non-inflamed
paw for comparison.
The average percent increase in paw volume with
time was calculated and compared against the control
group. Percent inhibition was calculated using the
formula-
% Inhibition of paw edema ¼ Vc−V t
V c
 100
Where, Vc and Vt represent average paw volume of
control and treated animal respectively.
Evaluation of in vitro anti-inflammatory activity
The reaction mixture (5 mL) consisted of 0.2 mL of egg
albumin (from fresh hen’s egg), 2.8 mL of phosphate
buffered saline (PBS, pH 6.4) and 2 mL of varying con-
centrations of extract so that final concentrations be-
come 100, 200, 300, 400, 500 μg/mL. Similar volume of
double-distilled water served as control. Then the mix-
tures were incubated at (37°C ± 2) in a BOD incubator
(Lab line Technologies) for 15 min and then heated at
70°C for 5 min. After cooling, their absorbance was
measured at 660 nm (SHIMADZU, UV 1800) by using
vehicle as blank. Acetyl salicylic Acid at the final con-
centration of (100, 200, 300, 400, 500μg/mL) was used
as reference drug and treated similarly for determin-
ation of absorbance.
The percentage inhibition of protein denaturation was
calculated by using the following formula:
% Inhibition ¼ Abscontrol−Abstest
Abscontrol
 100
Figure 5 Comparison curve of Curcuma zedoaria with control group and standard group (Early phase).
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The data are expressed as the mean ± SEM analyzed by
one-way analysis of variance (ANOVA) and Dunnett’s
t-test was used as the test of significance. P value <0.05
was considered as the minimum level of significance.




Phytochemical screening of ethanol extract of C. zedoaria
revealed the presence of various bioactive components of
which tannins, saponins, gums & carbohydrates, reducing
sugar, alkaloid, steroids and terpenoids were the most
prominent. The result of phytochemical test has been
summarized in the Table 1.
Analgesic activity
Hot plate method
Results of hotplate test are presented in Table 2 and
Table 3 for the crude extract of C. zedoaria. The rhi-
zome extract of the plant significantly increased the re-
action time of heat sensation in mice at the doses of 250
and 500 mg/kg BW and the percentage protection is al-
most equivalent to the respective doses (Figure 1). In theFigure 6 Comparison curve of Curcuma zedoaria with control group a3rd hour of study, the extract increased the reaction
time of heat sensation to 61.99% and 78.22% at the doses
of 250 and 500 mg/kg BW respectively while that of the
standard drug was 74% and the results were found to be
highly statistically significant (P < 0.001). The extract ex-
hibited a dose dependent increase in latency time when
compared with control (Figure 2).
Acetic acid-induced writhing test
Inhibition of licking response in mice due to the admin-
istration of the test drugs during acetic acid-induced
writhing test is shown in Table 4. The oral administration
of both doses of C. zedoaria rhizome extract significantly
(p < 0.001) attenuated the acetic acid-induced abdominal
writhes in mice in a dose dependent fashion (Figure 3).
The percent inhibition of writhing response by the extract
was 48.28% and 54.02% at 250 and 500 mg/kg doses re-
spectively while the standard Diclofenac sodium (10 mg/kg)
showed 64.36% inhibition in comparison with the control
(Figure 4).
Formalin-induced writhing test
The effect of the extract of C. zedoaria on formalin in-
duced pain in mice is shown in Table 3. The extract sig-
nificantly inhibited the licking response in both the earlynd standard group (Late phase).
Figure 7 Percentage inhibition graph of Curcuma zedoaria by
formic acid (Early phase).
Figure 9 Comparison chart of Anti-inflammatory of Curcuma
zedoaria with Control & Standard group.
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500 mg/kg, p < 0.01) and the late phase (58.42% at
250 mg/kg, p < 0.05 and 62.37% at 500 mg/kg, p < 0.01)
of the formalin test which were comparable to those of
the standard drug (Table 5 & Table 6, Figure 5, Figure 6,
Figure 7 & Figure 8). Both these inhibitions were dose
dependent.
Anti-inflammatory test result
In vivo anti-inflammatory test result
The anti-inflammatory effects of the extract and stand-
ard drug are presented in Table 4. In control animals,
the subplantar injection of carrageenan produced a local
edema that increased progressively to reach a maximal
intensity 3 hours after injection (Figure 9 & Figure 10).
The oral administration of both doses of the ethanolic
rhizome extract of C. zedoaria significantly (p < 0.05, p <
0.01 and p < 0.001) inhibited inflammatory response in-
duced by carrageenan in rats in a dose related manner
(Table 7). The most prominent inhibition of 92.02% at
250 mg/kg and 94.67% at 500 mg/kg were observed at
the 3rd hour of study after which the inhibitory activityFigure 8 Percentage inhibition graph of Curcuma zedoaria by
formic acid (Late phase).was found to decline (Table 8 & Figure 11). The result
was found to be highly statistically significant at 3rd
hour after administration of the sample drugs (p < 0.001)
(Table 7).
In vitro anti-inflammatory result
In the present study for in vitro anti-inflammatory test,
the ethanol extract, of C.zedoaria showed mean inhib-
ition of protein denaturation of 77.15, 64.43, 53.04, 36.78
and 23.70% for doses of 500, 400, 300, 200 and 100 μg/mL
respectively, whereas, for ASA it was found to be 88.06,
80.25, 77.18, 69.58 and 50.56% for same doses respectively
(Table 9 & Figure 12). The ethanolic extracts of C.
zedoaria showed good anti-inflammatory activity with a
linear response. Maximum inhibition of 77.15 ± 2.93%
was observed at 500 μg/mL and standard anti-
inflammatory drug (Aspirin) showed the maximum inhib-
ition, 88.06 ± 2.07% at the concentration of 500 μg/mL.
The ability of extract of C.zedoaria to inhibit thermal de-
naturation of protein was found to be statistically signifi-
cant (p < 0.05). In conclusion, further investigations are
needed to identify the active constituents and the exact
mechanism(s) of action responsible for the reportedFigure 10 Graph showing the anti-inflammatory activity of the
ethanol extract of Curcuma zedoaria using carrageenan
induced rat paw edema method.
Table 7 Anti-inflammatory activity study of the ethanol extract of Curcuma zedoaria using carrageenan induced rat
paw edema method
Treatment group 0 hour 1 hour 3 hours 6 hours 9 hours 12 hours
Control 0.7760 ± 0.02600 0.9040 ± 0.03855 1.1560 ± 0.04665 1.3520 ± 0.04247 1.4880 ± 0.03527 1.3700 ± .04159
Standard 0.8080 ± 0.01772 1.2720 ± 0.04521*** 1.5820 ± 0.02417*** 1.2020 ± 0.03541** 0.9900 ± 0.02608 0.8460 ± .00812
C.zedoaria 250 mg/kg (n = 5) 0.8280 ± .01772 1.1700 ± 0.07530** 1.590 ± 0.03619*** 1.2240 ± 0.03043** 1.0940 ± 0.02909 0.8840 ± .02926
C.zedoaria 500 mg/kg (n = 5) 0.7920 ± .03153 1.0580 ± .03541** 1.5420 ± .03441*** 1.2660 ± .04069** 0.9940 ± .02638 0.8320 ± .02396
All values are Mean ± SEM, n = 5. One way Analysis of Variance (ANOVA) followed by Dennett’s test was performed as the test of significance. The minimum value
of p < 0.05 was considered significant. **p < 0.01, ***p < 0.001 as compared with control group.
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zedoaria.
Discussion
Phytochemical investigation of the ethanolic rhizome
extract of Curcuma zedoaria indicates the presence of
tannins, alkaloids, flavonoids, gum and carbohydrates,
reducing sugar and terpenoids. The presence of these
chemicals represents the possibility of some biological
activity of the ethanolic rhizome extract of Curcuma
zedoaria.
A variety of pharmacological activities has been attrib-
uted to flavonoid compounds. Some flavonoids are re-
ported to have analgesic and anti-inflammatory activities
[21-23]. Some flavonoids can significantly inhibit a num-
ber of inflammatory mediators [24]. Terpenoids also
possess significant analgesic and anti-inflammatory ac-
tivities [25,26]. Such activity has been attributed to the
ability to inhibit phospholipase A2 and thereby ultim-
ately blocking the metabolism of arachidonic acid [27].
A number of alkaloids may also prevent inflammation
through blocking the metabolic pathway of arachidonic
acid [28,29].
The hot plate test measures the response to a brief,
noxious stimulus having a close resemblance to clinical
pain. This test measures the complex feedback to a non-
inflammatory, acute nociceptive input and is one of the
models normally used for studying central nociceptive
activity [30]. The method is considered to be selective
for the drugs acting centrally. It is a fact that any agent
that causes a prolongation of the hot plate latency using
this test must be acting centrally [31]. The ethanolicTable 8 Percentage inhibition of Curcuma zedoaria at
different time intervals
% inhibition
Group 1 hour 3 hours 6 hours 9 hours 12 hours
Standard 57.42 95.79 48.76 22.52 5.00
250 mg/kg 44.80 92.02 47.20 32.12 6.76
500 mg/kg 33.56 94.67 59.85 25.13 5.05rhizome extract of C. zedoaria presented a longer la-
tency time than the control group in the hot plate test
in a dose related manner. Therefore, the extract has ac-
tivity on central nervous system.
Acetic acid induced writhing response in mice, associ-
ated to visceral pain, finds much attention to evaluate
peripherally active analgesics [32]. Pain sensation in
acetic acid induced writhing method is obtained by gen-
erating localized inflammatory response resulting in re-
lease of free arachidonic acid from tissue phospholipid
via cyclooxygenase and prostaglandin biosynthesis [33].
The boost in prostaglandin levels within the peritoneal
cavity then raises inflammatory pain by rising capillary
permeability [34]. The agent lessening the number of
twitching will render analgesic effect preferably by re-
striction of prostaglandin synthesis, a peripheral mech-
anism of pain inhibition [33]. In the present study, the
crude extract produced significant analgesic effect which
might be due to the presence of analgesic principles act-
ing with the prostaglandin alley.
The formalin test is a model of continuing pain includ-
ing peripheral inflammation and central sensitization. The
method exhibits a biphasic reaction comprising of an early
(neurogenic) and a late (inflammatory) phase reaction and
originates mainly from neurogenic inflammation followed
by participation of kinins and leukocytes with their
pro-inflammatory factors including prostaglandins [35].
It is also reported that acute inflammation convinced
by formalin results from cell injury which serves the
production of endogenous mediators [36]. Results of
the present study show that the plant extract produced
antinociception against both neurogenic and inflamma-
tory phase of formalin induction. The fact that the ex-
tract at the doses tested produced analgesia in all
nociceptive models is indicative that it possesses both
central and peripheral antinociceptive effects and the
mechanism of action of the extract could, in part, be re-
lated to lipooxygenase and/or cyclooxygenase of the
arachidonic acid cascade and/or opioid receptors.
Carrageenan-induced inflammation is commonly used
model for assessing the anti-inflammatory potency of
compounds or natural products [37]. The probable
Figure 11 Graph showing the % of inhibition of the ethanol extract of Curcuma zedoaria using carrageenan induced rat paw
edema method.
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mation is bi-phasic, the first phase is characterised by
the release of histamine, serotonin and kinins in the
first hour; while the second phase is attributed to the
release of prostaglandins and lysosome enzymes in 2 to
4 hours [38]. The second phase is sensitive to most
clinically valid anti-inflammatory drugs [39]. The results
of present study reveal that the extract significantly inhib-
ited the carrageenan-induced acute inflammation in the
3rdhour of study and was comparable to that of the stand-
ard diclofenac sodium. So, the anti-inflammatory effect






Standard (Acetyl Salicylic Acid) 500 88.06 ± 2.07***
400 80.25 ± 1.34***
300 77.18 ± 1.45***
200 69.58 ± 0.83***
100 50.56 ± 1.36**
Ethanol Extract of
Curcuma zedoaria (Rhizome)
500 77.15 ± 2.93***
400 64.43 ± 4.27***
300 53.04 ± 2.65**
200 36.78 ± 5.16**
100 23.70 ± 3.06*
All values are Mean ± SEM, n = 3. One way Analysis of Variance (ANOVA)
followed by Dennett’s test was performed as the test of significance. The
minimum value of p < 0.05 was considered significant. *p < 0.05, **p < 0.01,
***p < 0.001 as compared with control group.action on prostaglandin, protease or lysosome synthesis
or activity.
The method of anti-denaturation of egg albumin was
chosen to evaluate anti-inflammatory property of C.
zedoaria. In anti-denaturation assay the denaturation of
egg albumin is induced by heat treatment. The dena-
tured protein expresses antigens associated to Type III
hyper-sensitive reaction which are related to diseases
such as serum sickness, glomerulo-nephritis etc. [40].
Heat-denatured proteins are as effective as native pro-
teins in provoking delayed hypersensitivity [41]. More-
over, it was already proved that conventional NSAID’s
like phenylbutazone and indomethazine do not act only
by the inhibition of endogenous prostaglandins produc-
tion by blocking COX enzyme but also by prevention of
denaturation of proteins [42]. Thus anti-denaturation
assay is the convenient method to check the anti-
inflammatory activity. From the result of the present study,
the extract has shown considerable anti-inflammatory ac-
tivity. C.zedoaria is capable of controlling the production
of auto antigen and thereby it inhibits the denaturation of
proteins and its effect was compared with the standard
drug Aspirin. The secondary metabolites like phenolic
compounds and tannins which were found in preliminary
phytochemical screening might be responsible for this ac-
tivity.
Conclusion
Based on the present investigation, it can be concluded that
the antinociceptive & in-vivo & in-vitro anti-inflammatory
activity of the rhizome extract of Curcuma zedoaria
might be attributed to the presence of the plant’s various
secondary metabolites like tannins, saponins, steroids,
Figure 12 Comparison curve of Acetyl Salicylic Acid with Curcuma zedoaria.
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These experimental findings support the traditional use of
this plant for the treatment of various ailments especially
against pain and inflammatory conditions. However, fur-
ther investigations are required to isolate the active con-
stituents responsible for the observed effect, and to
elucidate the possible mechanisms of action responsible
for the antinociceptive and anti-inflammatory activities of
the plant extract.
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